nodes	percent_of_prediction	percent_of_DWPC	metapath
Latanoprost—SLC22A1—Progesterone—uterine cancer	0.547	1	CbGbCtD
Latanoprost—PTGFR—corpus luteum—uterine cancer	0.129	0.584	CbGeAlD
Latanoprost—Exacerbation of asthma—Progesterone—uterine cancer	0.0173	0.0782	CcSEcCtD
Latanoprost—Macular oedema—Medroxyprogesterone Acetate—uterine cancer	0.0167	0.0758	CcSEcCtD
Latanoprost—PTGFR—myometrium—uterine cancer	0.0141	0.0642	CbGeAlD
Latanoprost—Bimatoprost—AKR1C3—uterine cancer	0.0123	1	CrCbGaD
Latanoprost—PTGFR—smooth muscle tissue—uterine cancer	0.0107	0.0485	CbGeAlD
Latanoprost—PTGFR—uterus—uterine cancer	0.00916	0.0416	CbGeAlD
Latanoprost—PTGFR—female reproductive system—uterine cancer	0.00824	0.0374	CbGeAlD
Latanoprost—PTGFR—female gonad—uterine cancer	0.0075	0.034	CbGeAlD
Latanoprost—Embolism—Progesterone—uterine cancer	0.00702	0.0318	CcSEcCtD
Latanoprost—Embolism—Medroxyprogesterone Acetate—uterine cancer	0.00636	0.0288	CcSEcCtD
Latanoprost—SLCO2B1—decidua—uterine cancer	0.00578	0.0262	CbGeAlD
Latanoprost—SLCO2B1—renal system—uterine cancer	0.00567	0.0258	CbGeAlD
Latanoprost—SLC22A1—renal system—uterine cancer	0.00542	0.0246	CbGeAlD
Latanoprost—SLCO2B1—uterus—uterine cancer	0.00505	0.0229	CbGeAlD
Latanoprost—PTGFR—lymph node—uterine cancer	0.00482	0.0219	CbGeAlD
Latanoprost—SLCO2B1—female reproductive system—uterine cancer	0.00454	0.0206	CbGeAlD
Latanoprost—SLCO2B1—female gonad—uterine cancer	0.00413	0.0188	CbGeAlD
Latanoprost—SLC22A1—vagina—uterine cancer	0.00393	0.0178	CbGeAlD
Latanoprost—Hepatic function abnormal—Progesterone—uterine cancer	0.00374	0.017	CcSEcCtD
Latanoprost—Hepatic function abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00339	0.0154	CcSEcCtD
Latanoprost—Diplopia—Progesterone—uterine cancer	0.00327	0.0148	CcSEcCtD
Latanoprost—Asthma—Progesterone—uterine cancer	0.00283	0.0128	CcSEcCtD
Latanoprost—Angina pectoris—Progesterone—uterine cancer	0.00276	0.0125	CcSEcCtD
Latanoprost—Bronchitis—Progesterone—uterine cancer	0.00272	0.0123	CcSEcCtD
Latanoprost—SLCO2B1—lymph node—uterine cancer	0.00266	0.0121	CbGeAlD
Latanoprost—Upper respiratory tract infection—Progesterone—uterine cancer	0.00263	0.0119	CcSEcCtD
Latanoprost—Pain—Carboplatin—uterine cancer	0.00262	0.0119	CcSEcCtD
Latanoprost—Asthma—Medroxyprogesterone Acetate—uterine cancer	0.00256	0.0116	CcSEcCtD
Latanoprost—Bronchitis—Medroxyprogesterone Acetate—uterine cancer	0.00247	0.0112	CcSEcCtD
Latanoprost—Conjunctivitis—Progesterone—uterine cancer	0.00245	0.0111	CcSEcCtD
Latanoprost—Urinary tract infection—Progesterone—uterine cancer	0.00245	0.0111	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Medroxyprogesterone Acetate—uterine cancer	0.00238	0.0108	CcSEcCtD
Latanoprost—Inflammation—Etoposide—uterine cancer	0.00238	0.0108	CcSEcCtD
Latanoprost—Connective tissue disorder—Progesterone—uterine cancer	0.00222	0.0101	CcSEcCtD
Latanoprost—Urinary tract infection—Medroxyprogesterone Acetate—uterine cancer	0.00222	0.0101	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Dactinomycin—uterine cancer	0.00208	0.00943	CcSEcCtD
Latanoprost—Mediastinal disorder—Progesterone—uterine cancer	0.00204	0.00924	CcSEcCtD
Latanoprost—Connective tissue disorder—Medroxyprogesterone Acetate—uterine cancer	0.00202	0.00913	CcSEcCtD
Latanoprost—Embolism—Epirubicin—uterine cancer	0.00201	0.00912	CcSEcCtD
Latanoprost—Keratitis—Epirubicin—uterine cancer	0.00199	0.00902	CcSEcCtD
Latanoprost—Erythema—Progesterone—uterine cancer	0.00197	0.00892	CcSEcCtD
Latanoprost—Back pain—Progesterone—uterine cancer	0.00191	0.00863	CcSEcCtD
Latanoprost—Embolism—Doxorubicin—uterine cancer	0.00186	0.00844	CcSEcCtD
Latanoprost—Vision blurred—Progesterone—uterine cancer	0.00186	0.00841	CcSEcCtD
Latanoprost—Mediastinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00185	0.00837	CcSEcCtD
Latanoprost—Keratitis—Doxorubicin—uterine cancer	0.00184	0.00835	CcSEcCtD
Latanoprost—Erythema—Medroxyprogesterone Acetate—uterine cancer	0.00179	0.00809	CcSEcCtD
Latanoprost—Dermatitis atopic—Epirubicin—uterine cancer	0.00175	0.00791	CcSEcCtD
Latanoprost—Back pain—Medroxyprogesterone Acetate—uterine cancer	0.00173	0.00782	CcSEcCtD
Latanoprost—Arthralgia—Progesterone—uterine cancer	0.00168	0.0076	CcSEcCtD
Latanoprost—Chest pain—Progesterone—uterine cancer	0.00168	0.0076	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.00167	0.00754	CcSEcCtD
Latanoprost—Discomfort—Progesterone—uterine cancer	0.00166	0.00751	CcSEcCtD
Latanoprost—Dermatitis atopic—Doxorubicin—uterine cancer	0.00162	0.00732	CcSEcCtD
Latanoprost—Oedema—Progesterone—uterine cancer	0.00161	0.00728	CcSEcCtD
Latanoprost—Stinging—Epirubicin—uterine cancer	0.0016	0.00722	CcSEcCtD
Latanoprost—Nervous system disorder—Progesterone—uterine cancer	0.00158	0.00714	CcSEcCtD
Latanoprost—Skin disorder—Progesterone—uterine cancer	0.00156	0.00707	CcSEcCtD
Latanoprost—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	0.00152	0.00688	CcSEcCtD
Latanoprost—Chest pain—Medroxyprogesterone Acetate—uterine cancer	0.00152	0.00688	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.00151	0.00684	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Etoposide—uterine cancer	0.00151	0.00683	CcSEcCtD
Latanoprost—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.0015	0.0068	CcSEcCtD
Latanoprost—Stinging—Doxorubicin—uterine cancer	0.00148	0.00668	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Progesterone—uterine cancer	0.00147	0.00663	CcSEcCtD
Latanoprost—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.00146	0.0066	CcSEcCtD
Latanoprost—Dyspnoea—Progesterone—uterine cancer	0.00143	0.00649	CcSEcCtD
Latanoprost—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00143	0.00647	CcSEcCtD
Latanoprost—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.00142	0.00641	CcSEcCtD
Latanoprost—Lacrimation increased—Epirubicin—uterine cancer	0.0014	0.00635	CcSEcCtD
Latanoprost—Erythema—Dactinomycin—uterine cancer	0.00139	0.00631	CcSEcCtD
Latanoprost—Pain—Progesterone—uterine cancer	0.00138	0.00623	CcSEcCtD
Latanoprost—Inflammation—Epirubicin—uterine cancer	0.00133	0.00603	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00133	0.00601	CcSEcCtD
Latanoprost—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.0013	0.00588	CcSEcCtD
Latanoprost—Lacrimation increased—Doxorubicin—uterine cancer	0.0013	0.00588	CcSEcCtD
Latanoprost—Inflammation—Doxorubicin—uterine cancer	0.00123	0.00558	CcSEcCtD
Latanoprost—Dry eye—Epirubicin—uterine cancer	0.00119	0.00541	CcSEcCtD
Latanoprost—Discomfort—Dactinomycin—uterine cancer	0.00117	0.0053	CcSEcCtD
Latanoprost—Pruritus—Progesterone—uterine cancer	0.00114	0.00515	CcSEcCtD
Latanoprost—Oedema—Dactinomycin—uterine cancer	0.00114	0.00515	CcSEcCtD
Latanoprost—Dry eye—Doxorubicin—uterine cancer	0.0011	0.005	CcSEcCtD
Latanoprost—Hepatic function abnormal—Epirubicin—uterine cancer	0.00107	0.00486	CcSEcCtD
Latanoprost—Dizziness—Progesterone—uterine cancer	0.00106	0.00482	CcSEcCtD
Latanoprost—Eczema—Epirubicin—uterine cancer	0.00104	0.00473	CcSEcCtD
Latanoprost—Mediastinal disorder—Etoposide—uterine cancer	0.00104	0.00473	CcSEcCtD
Latanoprost—Eye pain—Epirubicin—uterine cancer	0.00104	0.00471	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.00104	0.00469	CcSEcCtD
Latanoprost—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00103	0.00467	CcSEcCtD
Latanoprost—Rash—Progesterone—uterine cancer	0.00101	0.00459	CcSEcCtD
Latanoprost—Dermatitis—Progesterone—uterine cancer	0.00101	0.00459	CcSEcCtD
Latanoprost—Headache—Progesterone—uterine cancer	0.00101	0.00456	CcSEcCtD
Latanoprost—Hepatic function abnormal—Doxorubicin—uterine cancer	0.000994	0.0045	CcSEcCtD
Latanoprost—Back pain—Etoposide—uterine cancer	0.000975	0.00442	CcSEcCtD
Latanoprost—Pain—Dactinomycin—uterine cancer	0.000972	0.0044	CcSEcCtD
Latanoprost—Eczema—Doxorubicin—uterine cancer	0.000966	0.00437	CcSEcCtD
Latanoprost—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000964	0.00436	CcSEcCtD
Latanoprost—Eye pain—Doxorubicin—uterine cancer	0.000962	0.00435	CcSEcCtD
Latanoprost—Diplopia—Epirubicin—uterine cancer	0.000938	0.00425	CcSEcCtD
Latanoprost—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000919	0.00416	CcSEcCtD
Latanoprost—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000918	0.00416	CcSEcCtD
Latanoprost—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000913	0.00413	CcSEcCtD
Latanoprost—Diplopia—Doxorubicin—uterine cancer	0.000868	0.00393	CcSEcCtD
Latanoprost—Chest pain—Etoposide—uterine cancer	0.000858	0.00389	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000852	0.00386	CcSEcCtD
Latanoprost—Discomfort—Etoposide—uterine cancer	0.000848	0.00384	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.000845	0.00383	CcSEcCtD
Latanoprost—Asthma—Epirubicin—uterine cancer	0.000811	0.00367	CcSEcCtD
Latanoprost—Skin disorder—Etoposide—uterine cancer	0.000799	0.00362	CcSEcCtD
Latanoprost—Angina pectoris—Epirubicin—uterine cancer	0.00079	0.00358	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.000782	0.00354	CcSEcCtD
Latanoprost—Bronchitis—Epirubicin—uterine cancer	0.00078	0.00353	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000754	0.00341	CcSEcCtD
Latanoprost—Asthma—Doxorubicin—uterine cancer	0.000751	0.0034	CcSEcCtD
Latanoprost—Dyspnoea—Etoposide—uterine cancer	0.000734	0.00332	CcSEcCtD
Latanoprost—Angina pectoris—Doxorubicin—uterine cancer	0.000731	0.00331	CcSEcCtD
Latanoprost—Bronchitis—Doxorubicin—uterine cancer	0.000722	0.00327	CcSEcCtD
Latanoprost—Rash—Dactinomycin—uterine cancer	0.000717	0.00325	CcSEcCtD
Latanoprost—Pain—Etoposide—uterine cancer	0.000704	0.00319	CcSEcCtD
Latanoprost—Urinary tract infection—Epirubicin—uterine cancer	0.000703	0.00318	CcSEcCtD
Latanoprost—Conjunctivitis—Epirubicin—uterine cancer	0.000703	0.00318	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000698	0.00316	CcSEcCtD
Latanoprost—Conjunctivitis—Doxorubicin—uterine cancer	0.00065	0.00294	CcSEcCtD
Latanoprost—Urinary tract infection—Doxorubicin—uterine cancer	0.00065	0.00294	CcSEcCtD
Latanoprost—Connective tissue disorder—Epirubicin—uterine cancer	0.000638	0.00289	CcSEcCtD
Latanoprost—Connective tissue disorder—Doxorubicin—uterine cancer	0.00059	0.00267	CcSEcCtD
Latanoprost—Mediastinal disorder—Epirubicin—uterine cancer	0.000585	0.00265	CcSEcCtD
Latanoprost—Pruritus—Etoposide—uterine cancer	0.000582	0.00264	CcSEcCtD
Latanoprost—Erythema—Epirubicin—uterine cancer	0.000565	0.00256	CcSEcCtD
Latanoprost—Back pain—Epirubicin—uterine cancer	0.000547	0.00247	CcSEcCtD
Latanoprost—Dizziness—Etoposide—uterine cancer	0.000544	0.00246	CcSEcCtD
Latanoprost—Mediastinal disorder—Doxorubicin—uterine cancer	0.000541	0.00245	CcSEcCtD
Latanoprost—Vision blurred—Epirubicin—uterine cancer	0.000533	0.00241	CcSEcCtD
Latanoprost—Erythema—Doxorubicin—uterine cancer	0.000523	0.00237	CcSEcCtD
Latanoprost—Rash—Etoposide—uterine cancer	0.000519	0.00235	CcSEcCtD
Latanoprost—Dermatitis—Etoposide—uterine cancer	0.000518	0.00235	CcSEcCtD
Latanoprost—Headache—Etoposide—uterine cancer	0.000516	0.00233	CcSEcCtD
Latanoprost—Back pain—Doxorubicin—uterine cancer	0.000506	0.00229	CcSEcCtD
Latanoprost—Vision blurred—Doxorubicin—uterine cancer	0.000493	0.00223	CcSEcCtD
Latanoprost—Chest pain—Epirubicin—uterine cancer	0.000481	0.00218	CcSEcCtD
Latanoprost—Arthralgia—Epirubicin—uterine cancer	0.000481	0.00218	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000478	0.00216	CcSEcCtD
Latanoprost—Discomfort—Epirubicin—uterine cancer	0.000475	0.00215	CcSEcCtD
Latanoprost—Oedema—Epirubicin—uterine cancer	0.000461	0.00209	CcSEcCtD
Latanoprost—Nervous system disorder—Epirubicin—uterine cancer	0.000452	0.00205	CcSEcCtD
Latanoprost—Skin disorder—Epirubicin—uterine cancer	0.000448	0.00203	CcSEcCtD
Latanoprost—Arthralgia—Doxorubicin—uterine cancer	0.000445	0.00202	CcSEcCtD
Latanoprost—Chest pain—Doxorubicin—uterine cancer	0.000445	0.00202	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000442	0.002	CcSEcCtD
Latanoprost—Discomfort—Doxorubicin—uterine cancer	0.00044	0.00199	CcSEcCtD
Latanoprost—Oedema—Doxorubicin—uterine cancer	0.000427	0.00193	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.00042	0.0019	CcSEcCtD
Latanoprost—Nervous system disorder—Doxorubicin—uterine cancer	0.000419	0.00189	CcSEcCtD
Latanoprost—Skin disorder—Doxorubicin—uterine cancer	0.000415	0.00188	CcSEcCtD
Latanoprost—Dyspnoea—Epirubicin—uterine cancer	0.000411	0.00186	CcSEcCtD
Latanoprost—Pain—Epirubicin—uterine cancer	0.000394	0.00179	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000389	0.00176	CcSEcCtD
Latanoprost—Dyspnoea—Doxorubicin—uterine cancer	0.000381	0.00172	CcSEcCtD
Latanoprost—Pain—Doxorubicin—uterine cancer	0.000365	0.00165	CcSEcCtD
Latanoprost—Pruritus—Epirubicin—uterine cancer	0.000326	0.00148	CcSEcCtD
Latanoprost—Dizziness—Epirubicin—uterine cancer	0.000305	0.00138	CcSEcCtD
Latanoprost—Pruritus—Doxorubicin—uterine cancer	0.000302	0.00137	CcSEcCtD
Latanoprost—Rash—Epirubicin—uterine cancer	0.000291	0.00132	CcSEcCtD
Latanoprost—Dermatitis—Epirubicin—uterine cancer	0.000291	0.00132	CcSEcCtD
Latanoprost—Headache—Epirubicin—uterine cancer	0.000289	0.00131	CcSEcCtD
Latanoprost—Dizziness—Doxorubicin—uterine cancer	0.000282	0.00128	CcSEcCtD
Latanoprost—Rash—Doxorubicin—uterine cancer	0.000269	0.00122	CcSEcCtD
Latanoprost—Dermatitis—Doxorubicin—uterine cancer	0.000269	0.00122	CcSEcCtD
Latanoprost—Headache—Doxorubicin—uterine cancer	0.000267	0.00121	CcSEcCtD
